Genis
PrivateLast Round
Corporate Funding
Apr 27, 2000
Total Funding Raised
$5.63M
Company Overview
Genis is a biotechnology company pioneering the development and application of therapeutic chitin derivatives for use in orthobiologics, pharmaceuticals, and dietary supplements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genis Comps
Public and private peers based on sector, stage, and business model.
Genis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 27, 2000 |
Key People
Founding team and executive leadership
Genis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
| M-ERA.NET | Grant |
Genis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genis's valuation, stock price, and market status.
